Cargando…

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Detalles Bibliográficos
Autores principales:	van Baar, Annieke C G, Meiring, Suzanne, Holleman, Frits, Hopkins, David, Mingrone, Geltrude, Devière, Jacques, Nieuwdorp, Max, Bergman, Jacques J G H M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Recent Advances in Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515106/ https://www.ncbi.nlm.nih.gov/pubmed/34497147 http://dx.doi.org/10.1136/gutjnl-2020-323931

Ejemplares similares

A Changed Gut Microbiota Diversity Is Associated With Metabolic Improvements After Duodenal Mucosal Resurfacing With Glucagon-Like-Peptide-1 Receptor Agonist in Type 2 Diabetes in a Pilot Study
por: Meiring, Suzanne, et al.
Publicado: (2022)

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
por: van Baar, Annieke C G, et al.
Publicado: (2020)

Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetes
por: Meiring, Suzanne, et al.
Publicado: (2022)

Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus
por: van Baar, Annieke C.G., et al.
Publicado: (2020)

Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
por: van Baar, Annieke C.G., et al.
Publicado: (2019)

Duodenal L cell density correlates with features of metabolic syndrome and plasma metabolites
por: van Baar, Annieke C G, et al.
Publicado: (2018)

OR30-07 Mixed Meal Tolerance Test (MMTT) Results from Revita-2, the First Randomized, Sham-Controlled, Double-Blind, Prospective, Multicenter Study of Duodenal Mucosal Resurfacing (DMR) Safety and Efficacy in Patients with Sub-Optimally Controlled Type 2 Diabetes (T2D)
por: Hopkins, David, et al.
Publicado: (2020)

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial
por: Mingrone, Geltrude, et al.
Publicado: (2022)

Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
por: Meiring, S., et al.
Publicado: (2022)

Machine learning in GI endoscopy: practical guidance in how to interpret a novel field
por: van der Sommen, Fons, et al.
Publicado: (2020)

Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
por: Hadefi, Alia, et al.
Publicado: (2021)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

Mechanisms of rhinovirus-induced asthma
por: Papadopoulos, Nikolaos G, et al.
Publicado: (2004)

Severe acute respiratory syndrome (SARS) in children: epidemiology, presentation and management
por: Leung, T.F, et al.
Publicado: (2003)

Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review
por: Bettenworth, Dominik, et al.
Publicado: (2019)

MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis –18 month's follow-up of 12 cases
por: Dev, Bhawna, et al.
Publicado: (2019)

Intestinal microbiota in functional bowel disorders: a Rome foundation report
por: Simrén, Magnus, et al.
Publicado: (2013)

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
por: Lawler, Mark, et al.
Publicado: (2018)

Symptomatic reflux disease: the present, the past and the future
por: Boeckxstaens, Guy, et al.
Publicado: (2014)

Expert opinions and scientific evidence for colonoscopy key performance indicators
por: Rees, Colin J, et al.
Publicado: (2016)

Modern diagnosis of GERD: the Lyon Consensus
por: Gyawali, C Prakash, et al.
Publicado: (2018)

Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
por: Waldman, Scott A, et al.
Publicado: (2018)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Big data in IBD: big progress for clinical practice
por: Seyed Tabib, Nasim Sadat, et al.
Publicado: (2020)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
por: Dufour, Jean-François, et al.
Publicado: (2020)

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
por: Chapelle, Nicolas, et al.
Publicado: (2020)

Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
por: Misselwitz, Benjamin, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
por: Gottlieb, Klaus, et al.
Publicado: (2021)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021)

Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022)

Understanding the role of the gut in undernutrition: what can technology tell us?
por: Thompson, Alex J, et al.
Publicado: (2021)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022)

Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
por: Rimola, Jordi, et al.
Publicado: (2022)

Understanding neuroimmune interactions in disorders of gut–brain interaction: from functional to immune-mediated disorders
por: Vanuytsel, Tim, et al.
Publicado: (2023)

SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
por: Luxenburger, Hendrik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7vbqqasq0d4i6bgb1ob656kv3